Mother of molecules

Lotte Bjerre Knudsen, Scientific Vice President at Novo Nordisk, discovered the molecule liraglutide and oversaw its journey from “underdog candidate” to a treatment for more than a million people with diabetes and obesity.


By Tove Iren Spissøy Gerhardsen |  Published 11 February 2018


In a podcast to mark International Day of Women and Girls in Science, Lotte reflects on her life inside and outside of the laboratory. How did she balance her career with being a single mum? What is her primary motivation? And how did Game of Thrones help her come to terms with the nickname ‘Mother of Liraglutide’. 


Want to read more?


Simone talks about her heart issues in relation to type 2 diabetes

 

From the heart

Simone, an employee of Novo Nordisk, reflects on her perpetual battles with type 2 diabetes, heart disease and stigmatisation.

Life with type 2 diabetes together with heart disease

 

Tablets


The pursuit of oral insulin

Novo Nordisk Chief science officer Mads Krogsgaard Thomsen reflects on the past, present and future of insulin in a tablet.

Oral insulin remains the ‘Holy Grail’ of diabetes

 


Subscribe to Perspectives





Related to this article
 


Research & Development

We continuously turn science and technologies into the next generation of efficacious and safe biological medicines. 

Learn about Novo Nordisk R&D

 


Henning Hvid, research scientist at Novo Nordisk

 

Our history of
protein design

Our long-standing history in protein and peptide design is used to turn ideas into new investigative compounds. 

Learn more about our protein expertise

Our history of
protein design

Our long-standing history in protein and peptide design is used to turn ideas into new investigative compounds. 

Learn more about our protein expertise